Compare ROIV & EC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROIV | EC |
|---|---|---|
| Founded | 2014 | 1948 |
| Country | United Kingdom | Colombia |
| Employees | 721 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 32.9B |
| IPO Year | 2021 | 2008 |
| Metric | ROIV | EC |
|---|---|---|
| Price | $38.99 | $16.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $28.94 | N/A |
| AVG Volume (30 Days) | ★ 8.5M | 1.5M |
| Earning Date | 05-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 4.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $744.61 | N/A |
| P/E Ratio | ★ N/A | $170.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.50 | $8.57 |
| 52 Week High | $42.50 | $18.38 |
| Indicator | ROIV | EC |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 45.42 |
| Support Level | $33.15 | $16.29 |
| Resistance Level | $42.50 | $17.59 |
| Average True Range (ATR) | 1.45 | 0.52 |
| MACD | 0.05 | -0.08 |
| Stochastic Oscillator | 60.80 | 11.55 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Ecopetrol SA is engaged in commercial and industrial activities related to the exploration, exploitation, refining, transportation, storage, distribution, and marketing of hydrocarbons, their derivatives, and products, as well as the electric power transmission services, design, development, construction, operation, and maintenance of road and energy infrastructure projects and the provision of information technology and telecommunications services. The operations of the company are performed through four business segments: Exploration and Production, Transport and Logistics, Refining and Petrochemical, and Electric Power Transmission and Toll Roads Concessions. The majority of the company's revenue is generated from the Exploration and Production segment.